suberoyl bis-hydroxamic acid has been researched along with vorinostat in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brosch, G; Gerhäuser, C; Jung, M; Loidl, P; Scherf, H; Wittich, S; Xie, C | 1 |
| Burnett, R; Gottesfeld, JM; Herman, D; Jenssen, K; Perlman, SL; Soragni, E | 1 |
| Andrews, KT; Boyle, GM; Fairlie, DP; Gardiner, DL; Kahnberg, P; Le, GT; Lucke, AJ; Skinner-Adams, TS; Tran, TN | 1 |
| Cígler, P; Hoffman, HE; Jirásková, J; Konvalinka, J; Sanda, M; Schraml, J | 1 |
| Bradner, JE; Grachan, ML; Greenberg, EF; Haggarty, SJ; Mazitschek, R; Warnow, T; West, N | 1 |
| Brunel, JM; Castellano, R; Collette, Y; Dequiedt, F; Fabre, A; Garbit, S; Morelli, X; Restouin, A; Roche, P; Salmi-Smail, C | 1 |
| Bertrand, P; Blanquart, C; Bouchet, S; Cuendet, M; Lehotzky, A; Martinet, N; Nurisso, A; Ovadi, J; Simões-Pires, C; Zwick, V | 1 |
| Forgione, M; Hailu, GS; Mai, A; Robaa, D; Rotili, D; Sippl, W | 1 |
| Cassell, M; Lindsay, DS; Mitchell, SM; Reilly, CM; Strobl, JS | 1 |
1 review(s) available for suberoyl bis-hydroxamic acid and vorinostat
| Article | Year |
|---|---|
Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives.
Topics: Animals; Antiparasitic Agents; Drug Repositioning; Helminth Proteins; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Leishmania; Plasmodium; Protozoan Proteins; Schistosoma; Toxoplasma; Trypanosoma | 2017 |
8 other study(ies) available for suberoyl bis-hydroxamic acid and vorinostat
| Article | Year |
|---|---|
Structure-activity relationships on phenylalanine-containing inhibitors of histone deacetylase: in vitro enzyme inhibition, induction of differentiation, and inhibition of proliferation in Friend leukemic cells.
Topics: Acetylation; Animals; Antineoplastic Agents; Cell Differentiation; Cell Division; Enzyme Inhibitors; Friend murine leukemia virus; Histone Deacetylase Inhibitors; Histones; Leukemia, Experimental; Liver; Mice; Phenylalanine; Rats; Structure-Activity Relationship; Tumor Cells, Cultured; Zea mays | 2002 |
Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia.
Topics: Acetylation; Alleles; Anilides; Cell Line; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Frataxin; Friedreich Ataxia; Gene Expression Regulation; Gene Silencing; HeLa Cells; Heterochromatin; Histone Deacetylase Inhibitors; Histones; Humans; Iron-Binding Proteins; Molecular Structure; RNA, Messenger; Transcription, Genetic | 2006 |
Potent antimalarial activity of histone deacetylase inhibitor analogues.
Topics: Amino Acids, Dicarboxylic; Animals; Antimalarials; Cysteine; Drug Resistance; Enzyme Inhibitors; Erythrocytes; Histone Deacetylase Inhibitors; Humans; Models, Molecular; Parasitic Sensitivity Tests; Plasmodium falciparum; Sequence Homology, Amino Acid | 2008 |
Hydroxamic acids as a novel family of serine racemase inhibitors: mechanistic analysis reveals different modes of interaction with the pyridoxal-5'-phosphate cofactor.
Topics: Animals; Asparagine; Binding, Competitive; Enzyme Inhibitors; Hydroxamic Acids; Mice; Oximes; Pyridoxal Phosphate; Racemases and Epimerases; Structure-Activity Relationship | 2009 |
Chemical phylogenetics of histone deacetylases.
Topics: | 2010 |
Modified cap group suberoylanilide hydroxamic acid histone deacetylase inhibitor derivatives reveal improved selective antileukemic activity.
Topics: Animals; Antineoplastic Agents; Blood Cell Count; Cell Line, Tumor; Drug Screening Assays, Antitumor; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Leukemia; Mice; Models, Molecular; Repressor Proteins; Structure-Activity Relationship; Toxicity Tests, Chronic; Vorinostat | 2010 |
Cross metathesis with hydroxamate and benzamide BOC-protected alkenes to access HDAC inhibitors and their biological evaluation highlighted intrinsic activity of BOC-protected dihydroxamates.
Topics: Alkenes; Benzamides; Dose-Response Relationship, Drug; Formic Acid Esters; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2016 |
Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro.
Topics: Animals; Antiprotozoal Agents; Butyrates; Cattle; Cell Line; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Hydroxylamines; Inhibitory Concentration 50; Niacinamide; Parasitic Sensitivity Tests; Phenylbutyrates; Quinolines; Toxoplasma; Valproic Acid; Vitamin B Complex; Vorinostat | 2007 |